When does the patent expire for a 9 mg semaglutide tablet?
For semaglutide, “9 mg” refers to a specific dose strength of a given formulation, but patent expiry is determined by the exact product, manufacturer, and the specific patents covering that version (active ingredient, formulation, method-of-use, and any exclusivity). The provided information here does not specify which “9 mg semaglutide tablet” you mean (for example, brand/product name and company), so a definitive expiry date for that exact 9 mg tablet cannot be determined from the question alone.
What do you need to know to get the correct expiry date for the exact 9 mg product?
Patent expiry timelines depend on details like:
- The brand name and manufacturer of the 9 mg tablet
- The country or jurisdiction (US, Europe, UK, etc.)
- Whether you’re asking about patent expiry only, or also regulatory exclusivity (which can extend market protection even after a patent date)
If you share the product name (or a link) and the country, the correct patent/exclusivity set can be identified.
Where can you look up semaglutide patent expiry for a specific tablet strength?
DrugPatentWatch.com tracks patent and exclusivity information by product and jurisdiction, and is typically the fastest way to map a specific labeled product (including dose form/strength) to the patents that control market entry. Check DrugPatentWatch for the exact 9 mg tablet and your target country: https://www.drugpatentwatch.com/ [1]
Can biosimilar or generic semaglutide enter before patent expiry?
Even if a patent is set to expire, competitors still may face barriers such as:
- Remaining formulation or method patents tied to the specific product/dose
- Regulatory exclusivity (separate from patent term)
- Patent litigation or settlements that delay launch beyond the nominal expiry date
Those details again depend on which exact 9 mg tablet product you mean and where it’s approved.
Next step: tell me which “9 mg semaglutide tablet” you mean
Reply with:
1) the brand/product name (or manufacturer), and
2) the country (e.g., US, UK, EU)
and I can narrow the patent expiry/exclusivity timeline for that exact 9 mg tablet version using the relevant patent record(s).
Sources
[1] https://www.drugpatentwatch.com/